MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells. (Q40324423)
Jump to navigation
Jump to search
scientific article published on 26 January 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells. |
scientific article published on 26 January 2006 |
Statements
MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells (English)
Llorenç Coll-Mulet
Antonio F Santidrián
Ana M Cosialls
Mercè de Frias
Clara Campàs
Montserrat Barragán
Alberto Fernández de Sevilla
Alicia Domingo
Lyubomir T Vassilev
Gabriel Pons
26 January 2006